Company Description
Peak Bio (OTC: PKBO) is classified in the research and development in biotechnology industry within the Professional, Scientific, and Technical Services sector.
PKBO has declined 62.5% over the past year. Shares last traded at $0.0500.
This page collects what Stock Titan holds for PKBO, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Peak Bio (PKBO) stock last closed at $0.0500. Over the past 12 months, the stock has lost 62.5%.
Latest News
Peak Bio has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 5 with negative movement. Key topics include acquisition, management, clinical trial. View all PKBO news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
PKBO Company Profile & Sector Positioning
Peak Bio (PKBO) operates in the Research and Development in Biotechnology industry within the broader Professional, Scientific, and Technical Services sector and is listed on the OTC.